Sfoglia per Autore
Expression of Dicer and Drosha in triple-negative breast cancer
2012-01-01 Passon, N; Gerometta, A; Puppin, C; Lavarone, E; Puglisi, Fabio; Tell, Gianluca; DI LORETO, Carla; Damante, Giuseppe
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy. Anticancer Drugs
2012-01-01 Miscoria, M; Tonetto, F; Deroma, L; Machin, P; DI LORETO, Carla; Driol, P; Minisini, Am; Russo, S; Andreetta, C; Mansutti, M; Damante, Giuseppe; Fasola, G; Puglisi, Fabio
Primary therapy in breast cancer: what have we learned from landmark trials?
2013-01-01 Bozza, C.; Osa, E.; Puglisi, Fabio
Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
2013-01-01 Bonotto, M; Bozza, C; DI LORETO, Carla; Osa, Eo; Poletto, E; Puglisi, Fabio
Gene expression profiling in breast cancer: a clinical perspective.
2013-01-01 Arpino, G.; Generali, D.; Sapino, A.; Matro, L. D.; Frassoldati, A.; de Laurentis, M.; Paolo, P.; Mustacchi, G.; Cazzaniga, M.; Placido, S. D.; Conte, P.; Cappelletti, M.; Zanoni, V.; Antonelli, A.; Martinotti, M.; Puglisi, Fabio; Berruti, A.; Bottini, A.; Dogliotti, L.
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients
2013-01-01 Aprile, Giuseppe; Lutrino, Stefania Eufemia; Ferrari, Laura; Casagrande, Mariaelena; Bonotto, Marta; Ongaro, Elena; Puglisi, Fabio
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
2013-01-01 Lunardi, G; Piccioli, P; Bruzzi, P; Notaro, R; Lastraioli, S; Serra, M; Marroni, P; Bighin, C; Mansutti, M; Puglisi, Fabio; Porpiglia, M; Ponzone, R; Bisagni, G; Garrone, O; Cavazzini, G; Clavarezza, M; Del Mastro, L.
Risk factors and survival outcomes in patients with brain metastases from breast cancer
2013-01-01 Minisini, A. M.; Moroso, S.; Gerratana, L.; Giangreco, M.; Iacono, D.; Poletto, E.; Guardascione, M.; Fontanella, C.; Fasola, G.; Puglisi, Fabio
Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.
2013-01-01 Minisini, Am; Pascoletti, G; Intersimone, D; Poletto, E; Driol, P; Spizzo, R; Scott, Cathryn Anne; Puglisi, Fabio; Fasola, G; DI LORETO, Carla
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors
2013-01-01 Di Maio, M.; Bria, E.; Banna, Giuseppe L.; Puglisi, Fabio; Garassino, Marina C.; Lorusso, D.; Perrone, F.
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
2013-01-01 Gori, S.; Di Maio, M.; Pinto, C.; Alabiso, O.; Baldini, E.; Barbato, E.; Beretta, G. D.; Bravi, S.; Caffo, O.; Canobbio, L.; Carrozza, F.; Cinieri, S.; Cruciani, G.; Dinota, A.; Gebbia, V.; Giustini, L.; Graiff, C.; Molino, A.; Muggiano, A.; Pandoli, G.; Puglisi, Fabio; Tagliaferri, P.; Tomao, S.; Lunardi, G.; Venturini, M.
Bevacizumab in older patients with advanced colorectal or breast cancer
2013-01-01 Aprile, Giuseppe; Ferrari, Laura; Fontanella, Caterina; Puglisi, Fabio
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.
2013-01-01 Pegolo, E1; Puppin, C; Gerometta, A; Damante, Giuseppe; Puglisi, Fabio; DI LORETO, Carla
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
2013-01-01 Crivellari, D; Gray, K; Dellapasqua, S; Puglisi, F; Ribi, K; Price, K; H, Láng; I, ; Gianni, L; Spazzapan, S; Pinotti, G; Lüthi, J; Gelber, R; Regan, M; Colleoni, M; Castiglione-Gertsch, M; Maibach, R; Rabaglio, M; Coates, A; Goldhirsch, A.
Factors affecting patient's perception of anticancer treatments side-effects: an observational study.
2014-01-01 Russo, S.; Cinausero, M.; Gerratana, L.; Bozza, C.; Iacono, D.; Driol, P.; Deroma, L.; Sottile, R.; Fasola, G.; Puglisi, Fabio
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: A case-crossover study
2014-01-01 Foltran, Luisa; Aprile, Giuseppe; Pisa, Federica Edith; Ermacora, Paola; Pella, Nicoletta; Iaiza, Emiliana; Poletto, Elena; Lutrino, Stefania Eufemia; Mazzer, Micol; Giovannoni, Mariella; Cardellino, Giovanni Gerardo; Puglisi, Fabio; Fasola, Gianpiero
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
2014-01-01 G., v. Minckwitz; Puglisi, Fabio; Cortes, J.; Vrdoljak, E.; Marschner, E.; Zielinski, C.; Villanueva, C.; Romieu, G.; Lang, I.; Ciruelos, E.; De Laurentiis, M.; Veyret, C.; de Ducla, S.; Freudensprung, U.; Srock, S.; Gligorov, J.
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart?
2014-01-01 Fontanella, Caterina; Aita, Marianna; Cinausero, Marika; Aprile, Giuseppe; Fasola, Gianpiero; Puglisi, Fabio; Baldin, Maria Grazia; Dusi, Veronica; Lestuzzi, Chiara
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM)
2014-01-01 Pedrazzoli, Paolo; Baldanti, F.; Donatelli, I.; Castrucci, M. R.; Puglisi, Fabio; Silvestris, N.; Cinieri, S.
Follow-up of patients with early breast cancer: Is it time to rewrite the story?
2014-01-01 Puglisi, Fabio; Fontanella, Caterina; Numico, Gianmauro; Sini, Valentina; Evangelista, Laura; Monetti, Francesco; Gori, Stefania; Del Mastro, Lucia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Expression of Dicer and Drosha in triple-negative breast cancer | 1-gen-2012 | Passon, N; Gerometta, A; Puppin, C; Lavarone, E; Puglisi, Fabio; Tell, Gianluca; DI LORETO, Carla; Damante, Giuseppe | |
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy. Anticancer Drugs | 1-gen-2012 | Miscoria, M; Tonetto, F; Deroma, L; Machin, P; DI LORETO, Carla; Driol, P; Minisini, Am; Russo, S; Andreetta, C; Mansutti, M; Damante, Giuseppe; Fasola, G; Puglisi, Fabio | |
Primary therapy in breast cancer: what have we learned from landmark trials? | 1-gen-2013 | Bozza, C.; Osa, E.; Puglisi, Fabio | |
Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase? | 1-gen-2013 | Bonotto, M; Bozza, C; DI LORETO, Carla; Osa, Eo; Poletto, E; Puglisi, Fabio | |
Gene expression profiling in breast cancer: a clinical perspective. | 1-gen-2013 | Arpino, G.; Generali, D.; Sapino, A.; Matro, L. D.; Frassoldati, A.; de Laurentis, M.; Paolo, P.; Mustacchi, G.; Cazzaniga, M.; Placido, S. D.; Conte, P.; Cappelletti, M.; Zanoni, V.; Antonelli, A.; Martinotti, M.; Puglisi, Fabio; Berruti, A.; Bottini, A.; Dogliotti, L. | |
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients | 1-gen-2013 | Aprile, Giuseppe; Lutrino, Stefania Eufemia; Ferrari, Laura; Casagrande, Mariaelena; Bonotto, Marta; Ongaro, Elena; Puglisi, Fabio | |
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole | 1-gen-2013 | Lunardi, G; Piccioli, P; Bruzzi, P; Notaro, R; Lastraioli, S; Serra, M; Marroni, P; Bighin, C; Mansutti, M; Puglisi, Fabio; Porpiglia, M; Ponzone, R; Bisagni, G; Garrone, O; Cavazzini, G; Clavarezza, M; Del Mastro, L. | |
Risk factors and survival outcomes in patients with brain metastases from breast cancer | 1-gen-2013 | Minisini, A. M.; Moroso, S.; Gerratana, L.; Giangreco, M.; Iacono, D.; Poletto, E.; Guardascione, M.; Fontanella, C.; Fasola, G.; Puglisi, Fabio | |
Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma. | 1-gen-2013 | Minisini, Am; Pascoletti, G; Intersimone, D; Poletto, E; Driol, P; Spizzo, R; Scott, Cathryn Anne; Puglisi, Fabio; Fasola, G; DI LORETO, Carla | |
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors | 1-gen-2013 | Di Maio, M.; Bria, E.; Banna, Giuseppe L.; Puglisi, Fabio; Garassino, Marina C.; Lorusso, D.; Perrone, F. | |
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM). | 1-gen-2013 | Gori, S.; Di Maio, M.; Pinto, C.; Alabiso, O.; Baldini, E.; Barbato, E.; Beretta, G. D.; Bravi, S.; Caffo, O.; Canobbio, L.; Carrozza, F.; Cinieri, S.; Cruciani, G.; Dinota, A.; Gebbia, V.; Giustini, L.; Graiff, C.; Molino, A.; Muggiano, A.; Pandoli, G.; Puglisi, Fabio; Tagliaferri, P.; Tomao, S.; Lunardi, G.; Venturini, M. | |
Bevacizumab in older patients with advanced colorectal or breast cancer | 1-gen-2013 | Aprile, Giuseppe; Ferrari, Laura; Fontanella, Caterina; Puglisi, Fabio | |
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis. | 1-gen-2013 | Pegolo, E1; Puppin, C; Gerometta, A; Damante, Giuseppe; Puglisi, Fabio; DI LORETO, Carla | |
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. | 1-gen-2013 | Crivellari, D; Gray, K; Dellapasqua, S; Puglisi, F; Ribi, K; Price, K; H, Láng; I, ; Gianni, L; Spazzapan, S; Pinotti, G; Lüthi, J; Gelber, R; Regan, M; Colleoni, M; Castiglione-Gertsch, M; Maibach, R; Rabaglio, M; Coates, A; Goldhirsch, A. | |
Factors affecting patient's perception of anticancer treatments side-effects: an observational study. | 1-gen-2014 | Russo, S.; Cinausero, M.; Gerratana, L.; Bozza, C.; Iacono, D.; Driol, P.; Deroma, L.; Sottile, R.; Fasola, G.; Puglisi, Fabio | |
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: A case-crossover study | 1-gen-2014 | Foltran, Luisa; Aprile, Giuseppe; Pisa, Federica Edith; Ermacora, Paola; Pella, Nicoletta; Iaiza, Emiliana; Poletto, Elena; Lutrino, Stefania Eufemia; Mazzer, Micol; Giovannoni, Mariella; Cardellino, Giovanni Gerardo; Puglisi, Fabio; Fasola, Gianpiero | |
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial. | 1-gen-2014 | G., v. Minckwitz; Puglisi, Fabio; Cortes, J.; Vrdoljak, E.; Marschner, E.; Zielinski, C.; Villanueva, C.; Romieu, G.; Lang, I.; Ciruelos, E.; De Laurentiis, M.; Veyret, C.; de Ducla, S.; Freudensprung, U.; Srock, S.; Gligorov, J. | |
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart? | 1-gen-2014 | Fontanella, Caterina; Aita, Marianna; Cinausero, Marika; Aprile, Giuseppe; Fasola, Gianpiero; Puglisi, Fabio; Baldin, Maria Grazia; Dusi, Veronica; Lestuzzi, Chiara | |
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) | 1-gen-2014 | Pedrazzoli, Paolo; Baldanti, F.; Donatelli, I.; Castrucci, M. R.; Puglisi, Fabio; Silvestris, N.; Cinieri, S. | |
Follow-up of patients with early breast cancer: Is it time to rewrite the story? | 1-gen-2014 | Puglisi, Fabio; Fontanella, Caterina; Numico, Gianmauro; Sini, Valentina; Evangelista, Laura; Monetti, Francesco; Gori, Stefania; Del Mastro, Lucia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile